Antibe Therapeutics Inc(Pre-Merger) ATBPF

(News Release)

[Duster340]

a few thoughts that come to mind, maybe just an attempt to keep the stock from dropping more (buying time for a hopeful financing deal). still no information on the cash situation "nuance payment due date". there has not been anymore insider buying only the 3 acquisitions from earlier this month. if they had some good news to tell us they would, so for me there is to much uncertainty, i will not touch it with a 10 foot pole.

[MrMugsy]

Let me help Duster ... 1.  I highly doubt that anyone is trying to control this stock price ... don't think anyone ever tried to do that.  Would love to meet them. 2.  No information - true. 3.  The insider buying was timed quickly ... so likely as a message to investors.  They never buy in reoccurring events and it would be surprising to see it again this month. 4

[FesticleShwartz]

I do not think they will go bankrupt, sounds like we are in a holding pattern until September for funding and P3 acute. All is not lost hopefully 

[Montana5]

An announcement that P2 has commenced (as was intended in Q1) would provide some confidence.

[Duster340]

How are they going to keep the lights on at the antibe office let alone fund a P2 trial?   Cash Position: As of December 31, 2023, the Company had available cash balance and term deposits totaling $24.9 million Antibe to refund the US$20 million upfront payment and pay interest and costs of approximately US$4 million. any kind of financing if they can get it will be dillutive and not

[Duster340]

of course management was trying to control the s.p. with there buying it eased share holder panic and the further sell-off of shares that was the message to investors. it buys them more time to raise cash, not hard to put 2+2 together but who will finance them, how can they convince anyone with an unproven drug when potential financers look closely they will see the drug has already failed on an